Constellium SE (NYSE:CSTM) Logo

Regions Financial Corp increased its stake in Vertex Pharmaceuticals Inc (VRTX) by 7.5% based on its latest 2019Q3 regulatory filing with the SEC. Regions Financial Corp bought 4,401 shares as the company’s stock rose 27.71% . The institutional investor held 63,046 shares of the major pharmaceuticals company at the end of 2019Q3, valued at $10.68M, up from 58,645 at the end of the previous reported quarter. Regions Financial Corp who had been investing in Vertex Pharmaceuticals Inc for a number of months, seems to be bullish on the $56.00 billion market cap company. The stock decreased 0.93% or $2.06 during the last trading session, reaching $218.49. About 596,914 shares traded. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has risen 24.30% since December 13, 2018 and is uptrending. It has outperformed by 24.30% the S&P500. Some Historical VRTX News: 26/04/2018 – VERTEX 1Q SYMDEKO REV. $34M, EST. $32.5M; 04/04/2018 – Q-State Biosciences and Vertex Pharmaceuticals Enter into Multi-Year Drug Discovery Collaboration; 04/05/2018 – STAT Plus: Watchdog says Vertex cystic fibrosis drugs are not cost effective, but company calls analysis a ‘sham’; 04/05/2018 – L3’s Vertex sold for single-digit adjusted EBITDA multiple, sources say [23:50 BST04 May 2018] [Proprietary] []; 30/05/2018 – FDA slaps a clinical hold on sickle cell IND filed by Vertex and CRISPR Therapeutics $VRTX $CRSP -20%; 26/04/2018 – Vertex Pharmaceuticals 1Q Adj EPS 76c; 27/04/2018 – A Phase III race. Yes! Vertex’s rapid-fire PhIII program hits a roadblock at the FDA. Will regulators force rival Galapagos to slow down too? $VRTX $GLPG; 20/03/2018 – L-3’s Vertex draws Platinum Equity, Veritas, sources say [20:51 GMT20 Mar 2018] [Proprietary] []; 20/03/2018 – L-3’s Vertex draws Platinum Equity, Veritas; 01/05/2018 – L3 Signs Definitive Agreement to Sell Its Vertex Aerospace Business to American Industrial Partners

Bronson Point Management Llc increased its stake in Constellium Nv (CSTM) by 3.57% based on its latest 2019Q3 regulatory filing with the SEC. Bronson Point Management Llc bought 57,000 shares as the company’s stock rose 13.94% . The hedge fund held 1.66M shares of the metal fabrications company at the end of 2019Q3, valued at $21.04 million, up from 1.60 million at the end of the previous reported quarter. Bronson Point Management Llc who had been investing in Constellium Nv for a number of months, seems to be bullish on the $2.00B market cap company. The stock increased 0.47% or $0.07 during the last trading session, reaching $14.87. About 346,733 shares traded. Constellium SE (NYSE:CSTM) has risen 72.65% since December 13, 2018 and is uptrending. It has outperformed by 72.65% the S&P500. Some Historical CSTM News: 27/04/2018 – Constellium posts Annual General Meeting Materials; 26/04/2018 – CONSTELLIUM 1Q ADJ EBITDA EU117M, EST. EU106.8M; 17/05/2018 – Constellium to expand operations in Decin, Czech Republic, to increase casting, recycling and extrusion capacity of aluminium profiles; 26/04/2018 – CONSTELLIUM NV – CONTINUE TO EXPECT ADJ EBITDA GROWTH IN HIGH SINGLE DIGITS ANNUALLY THROUGH 2020, LEADING TO OVER EUR 500 MLN OF ADJ EBITDA IN 2020; 26/04/2018 – Constellium Closes Above 50-Day Moving Average: Technicals; 26/04/2018 – CONSTELLIUM – CONTINUES TO EVALUATE RISK OF TEMPORARY SUPPLY DISRUPTIONS AS A RESULT OF U.S. SANCTIONS ON VARIOUS RUSSIAN INDIVIDUALS AND COMPANIES; 14/05/2018 – Primecap Adds Moody’s, Exits Constellium, Cuts Biogen: 13F; 15/05/2018 – Park West Asset Management Buys New 3% Position in Constellium; 02/05/2018 – Constellium supplies aluminium Auto Body Sheet for new Mercedes-Benz CLS model; 26/04/2018 – CONSTELLIUM NV – CURRENTLY EXPECTS TO BE ABLE TO MEET ITS ALUMINIUM CONSUMPTION REQUIREMENTS

More notable recent Constellium SE (NYSE:CSTM) news were published by: which released: “Constellium plans more aluminum recycling, CEO says – Seeking Alpha” on October 28, 2019, also with their article: “Constellium to Supply Airware® Aluminium Solutions to Blue Origin – GlobeNewswire” published on April 04, 2019, published: “Constellium Reports Third Quarter 2019 Results NYSE:CSTM – GlobeNewswire” on October 23, 2019. More interesting news about Constellium SE (NYSE:CSTM) were released by: and their article: “Constellium releases its 2018 Business and Sustainability Report, highlighting progress towards 2020 sustainability targets – GlobeNewswire” published on July 01, 2019 as well as‘s news article titled: “Constellium’s Ravenswood facility receives Department of Defense grant to optimize armor plate production – GlobeNewswire” with publication date: October 29, 2019.

Regions Financial Corp, which manages about $9.01 billion US Long portfolio, decreased its stake in Blackrock Fund Advisors (IJK) by 3,600 shares to 109,963 shares, valued at $24.62M in 2019Q3, according to the filing. It also reduced its holding in Lockheed Martin Corp (NYSE:LMT) by 91,678 shares in the quarter, leaving it with 76,075 shares, and cut its stake in Citigroup Inc (NYSE:C).

Investors sentiment increased to 1.31 in Q3 2019. Its up 0.14, from 1.17 in 2019Q2. It improved, as 37 investors sold VRTX shares while 166 reduced holdings. 62 funds opened positions while 204 raised stakes. 234.70 million shares or 0.28% less from 235.36 million shares in 2019Q2 were reported. Gateway Investment Advisers Ltd Co stated it has 0.24% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Citigroup Inc holds 319,698 shares. Pinebridge LP holds 0.01% or 2,420 shares in its portfolio. 18,229 are held by Trexquant Limited Partnership. Dakota Wealth holds 0.06% or 2,000 shares in its portfolio. Hillsdale Inv Mgmt Inc invested in 0.04% or 2,700 shares. Los Angeles Cap Mgmt & Equity Rech Incorporated owns 383,563 shares or 0.35% of their US portfolio. Eqis Cap Mgmt holds 0.15% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for 10,394 shares. Fukoku Mutual Life Insurance Co has invested 0.03% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Geode Mngmt Limited Liability stated it has 3.46M shares or 0.14% of all its holdings. Sumitomo Mitsui Tru Inc accumulated 1.22M shares or 0.18% of the stock. Retirement Of Alabama has invested 0.12% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Moreover, Icon Advisers Inc has 0.29% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Meag Munich Ergo Kapitalanlagegesellschaft Mbh reported 0.14% stake. Dana Invest Advsr owns 14,259 shares for 0.12% of their portfolio.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Source link